These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34972189)

  • 1. The role of Leishmania GP63 in the modulation of innate inflammatory response to Leishmania major infection.
    Chan A; Ayala JM; Alvarez F; Piccirillo C; Dong G; Langlais D; Olivier M
    PLoS One; 2021; 16(12):e0262158. PubMed ID: 34972189
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    da Silva Lira Filho A; Fajardo EF; Chang KP; Clément P; Olivier M
    Front Cell Infect Microbiol; 2021; 11():709258. PubMed ID: 35186777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of metalloprotease GP63 alters the protein content of Leishmania exosomes.
    Hassani K; Shio MT; Martel C; Faubert D; Olivier M
    PLoS One; 2014; 9(4):e95007. PubMed ID: 24736445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63).
    Joshi PB; Sacks DL; Modi G; McMaster WR
    Mol Microbiol; 1998 Feb; 27(3):519-30. PubMed ID: 9489664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection.
    Silverman JM; Reiner NE
    Front Cell Infect Microbiol; 2011; 1():26. PubMed ID: 22919591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases.
    Gomez MA; Contreras I; Hallé M; Tremblay ML; McMaster RW; Olivier M
    Sci Signal; 2009 Sep; 2(90):ra58. PubMed ID: 19797268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in Leishmania chemokine suppression driven by diversification of the GP63 virulence factor.
    Antonia AL; Barnes AB; Martin AT; Wang L; Ko DC
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009224. PubMed ID: 34710089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against Leishmania major in a CBA mouse model of infection: role of adjuvants and mechanism of protection.
    Rivier D; Bovay P; Shah R; Didisheim S; Mauël J
    Parasite Immunol; 1999 Sep; 21(9):461-73. PubMed ID: 10476055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania exosomes and other virulence factors: Impact on innate immune response and macrophage functions.
    Atayde VD; Hassani K; da Silva Lira Filho A; Borges AR; Adhikari A; Martel C; Olivier M
    Cell Immunol; 2016 Nov; 309():7-18. PubMed ID: 27499212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKC/ROS-Mediated NLRP3 Inflammasome Activation Is Attenuated by Leishmania Zinc-Metalloprotease during Infection.
    Shio MT; Christian JG; Jung JY; Chang KP; Olivier M
    PLoS Negl Trop Dis; 2015; 9(6):e0003868. PubMed ID: 26114647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of metalloproteases in Leishmania species infection in the New World: a systematic review.
    Murase LS; de Souza JVP; de Lima Neto QA; de Mello TFP; Cardoso BM; Lera-Nonose DSSL; Teixeira JJV; Lonardoni MVC; Demarchi IG
    Parasitology; 2018 Oct; 145(12):1499-1509. PubMed ID: 29530102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dok proteins are recruited to the phagosome and degraded in a GP63-dependent manner during Leishmania major infection.
    Álvarez de Celis H; Gómez CP; Descoteaux A; Duplay P
    Microbes Infect; 2015 Apr; 17(4):285-94. PubMed ID: 25554486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania major Promastigotes Evade LC3-Associated Phagocytosis through the Action of GP63.
    Matte C; Casgrain PA; Séguin O; Moradin N; Hong WJ; Descoteaux A
    PLoS Pathog; 2016 Jun; 12(6):e1005690. PubMed ID: 27280768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63.
    Connell ND; Medina-Acosta E; McMaster WR; Bloom BR; Russell DG
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11473-7. PubMed ID: 8265576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.
    Walker PS; Scharton-Kersten T; Rowton ED; Hengge U; Bouloc A; Udey MC; Vogel JC
    Hum Gene Ther; 1998 Sep; 9(13):1899-907. PubMed ID: 9741428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Leishmania metalloprotease GP63 on macrophage signaling.
    Isnard A; Shio MT; Olivier M
    Front Cell Infect Microbiol; 2012; 2():72. PubMed ID: 22919663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
    Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania virulence factors: focus on the metalloprotease GP63.
    Olivier M; Atayde VD; Isnard A; Hassani K; Shio MT
    Microbes Infect; 2012 Dec; 14(15):1377-89. PubMed ID: 22683718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63.
    Contreras I; Gómez MA; Nguyen O; Shio MT; McMaster RW; Olivier M
    PLoS Pathog; 2010 Oct; 6(10):e1001148. PubMed ID: 20976196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.